Drug intelligence / Profile preview

beta-cryptoxanthin

Development stage
Unknown
Lead developer
DSM Nutritional Products, Inc.
Modality
Small Molecules
Administration
Oral
01

Overview

Beta-cryptoxanthin (BCX) is a naturally occurring oxygenated carotenoid (xanthophyll) and provitamin A precursor found in various fruits and vegetables, including tangerines, red peppers, and pumpkins. It acts as a potent antioxidant and exerts its biological effects primarily through the activation of the Nrf2/HO-1 signaling pathway, which mitigates oxidative stress, and the modulation of retinoic acid receptors (RAR) following its bioconversion into retinoids. BCX has been investigated for its potential therapeutic and preventive roles in metabolic and degenerative conditions such as diabetic kidney disease, age-related macular degeneration, diabetic retinopathy, osteoporosis, and pancreatic cancer. While it is widely available as a dietary supplement and has been the subject of clinical research by the Institute for Human Development and Potential (IHDP) and DSM Nutritional Products, it is not currently approved as a pharmaceutical drug.

Other names
BCXβ-cryptoxanthin(3R)-beta,beta-caroten-3-ol
02

Targets

RARA (Retinoic acid receptor alpha)ROS/1O2 (Reactive oxygen species / singlet oxygen in lipid membranes)HMOX1 (Heme oxygenase 1)

Beyond the preview

Go deeper on beta-cryptoxanthin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-cryptoxanthin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call